← SynDRA
SB-243213
SynDRA canonical compound SYN0000758 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HTR2A | HTR2B | HTR2C | HTR6 |
|---|
| Mechanism of action | serotonin receptor inverse agonist |
|---|
All known targets
Mechanisms of action (all sources)
- HTR2A ANTAGONIST
- HTR2B ANTAGONIST
- HTR2C ANTAGONIST
- serotonin receptor inverse agonist
- HTR2C AGONIST
Cross-references
Synonyms
- AC1L9EKT
- UNII-R6MR8DB4PZ
- R6MR8DB4PZ
- CHEMBL14460
- CHEBI:8980
- sb 243213 dihydrochloride
- 5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-6-(trifluoromethyl)-2,3-dihydroindole-1-carboxamide
- 5-methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)-6-(trifluoromethyl)indoline-1-carboxamide
- 5-Methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)-6-(trifluoromethyl)-2,3-dihydro-1H-indole-1-carboxamide
- SB 243213
- RefChem:931340
- SB243213
- SB-243213 free base
- MFCD19981131
- SB-243213 dihydrochloride
- ZETBBVYSBABLHL-UHFFFAOYSA-N
- starbld0000862
- Pazopanib + Tyverb/Tykerb
- SureCN677610
- GTPL194
- SCHEMBL677610
- orb1692563
- SCHEMBL29697170
- SCHEMBL31060820
- C22H19F3N4O2
- BDBM50086065
- EBC-46097
- AKOS040756054
- HY-103112B
- NCGC00247938-01
- BS181806
- DA-77710
- MS-27577
- SY496650
- CS-0136899
- NS00015697
- SB-243,213
- G14069
- T37816
Look up SB-243213 in the interactive SynDRA portal →